Roivant Sciences Ltd. Insider Trading Activity

Average Profitability
30.04%
Insider Buys Quantity
6
Insider Buys Sum
$457.48M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Roivant Sciences Ltd.

According to the SEC Form 4 filings, Roivant Sciences Ltd., being in a position of

  1. at Immunovant, Inc.,
    оver the last 12 months, has bought 16666666 shares for $350M, and sold 0 shares,
    over all time since 2020-04-16, has bought 39116959 shares for $807.48M, and sold 0 shares.

Biography of Roivant Sciences Ltd.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $349,999,9861100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2025-12-12PurchaseImmunovant, Inc.
IMVT
16.67M
7.5524%
$21.00$350M+9.42%
2025-01-13PurchaseImmunovant, Inc.
IMVT
16.85M
10.1065%
$20.00$336.9M-23.16%
2023-10-02PurchaseImmunovant, Inc.
IMVT
1.53M
1.2813%
$38.00$58M-9.18%
2022-10-06PurchaseImmunovant, Inc.
IMVT
director
416,667
0.198%
$6.00$2.5M+85.03%
2022-10-06PurchaseImmunovant, Inc.
IMVT
director
833,334
0.396%
$6.00$5M+85.03%
2020-09-04PurchaseImmunovant, Inc.
IMVT
10 percent owner
760,000
0.8259%
$33.00$25.08M-53.75%
2020-04-16PurchaseImmunovant, Inc.
IMVT
10 percent owner
2.07M
2.2425%
$14.50$30M+43.07%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.